Menu
Back to Journals » Clinical Epidemiology » Volume 5 » Issue 1
Review
The NordiNet® International Outcome Study and NovoNet® ANSWER Program®: rationale, design, and methodology of two international pharmacoepidemiological registry-based studies monitoring long-term clinical and safety outcomes of growth hormone therapy (Norditropin®)
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 19,093 | Dovepress* | 13,893+ | 2,232 | 16,125 | |
| PubMed Central* | 5,200 | 1,083 | 6,283 | ||
| Totals | 19,093 | 3,315 | 22,408 | ||
|
*Since 26 April 2013 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 1 | 0 | 0 | 0 | 1 |
View citations on PubMed Central and Google Scholar